What is Debie Hoivik email address?

Debie Hoivik's primary email address is ************@boehringer-ingelheim.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Debie Hoivik work for?

Debie Hoivik is a Medicine Safety Evaluation at Akebia Therapeutics.

Where Debie Hoivik graduated from?

Debie Hoivik holds a degree in null from University of Connecticut.

How can I directly contact Debie Hoivik?

To contact Debie Hoivik directly, you can use the email address ************@boehringer-ingelheim.com. Complete contact information is available upon registration with Muraena.

Who is Debie Hoivik?

Debie Hoivik is an accomplished leader with over 20 years of experience in nonclinical drug safety and translational medicine. Currently serving as Vice President of Early Development at Akebia Therapeutics, Debie has a proven track record in overseeing nonclinical safety assessments for therapeutic candidates aimed at improving patient outcomes in kidney disease. Her extensive background includes significant roles at major pharmaceutical companies such as GSK and Boehringer Ingelheim, where she managed diverse operations and led strategic global projects. With a Ph.D. in Pharmacology and Toxicology from the University of Connecticut, Debie combines scientific expertise with strong leadership skills. Her interests lie in operational excellence and compliance within the pharmaceutical industry, making her a key asset in any organization focused on drug development and safety. Debie is also known for her adaptability in navigating complex regulatory environments and fostering collaboration across multidisciplinary teams.